NIH Updates COVID-19 Treatment Guidance on Corticosteroids, Advance Planning

Grace Halsey

The National Institutes of Health updated guidance on use of dexamethasone and substitutes in critically ill patients, and on ensuring surrogate decision makers are identified.

The National Institutes of Health (NIH) on July 30, 2020 made updates on use of corticosteroids in treatment of COVID-19 and on approaches to care of the crtically ill, including considerations for advance planning to its dynamic COVID-19 Treatment Guidelines. The guidelines are updated as soon as published data and other authoritative information become available. Following are highlights of the recent updates.